C4 Therapeutics, Inc. (CCCC) Discusses On Phase 1 Trial Data Of Cemsidomide In Multiple My
C4 Therapeutics(US:CCCC) Seeking Alphaยท2025-09-22 09:23PresentationPlease note this event is being recorded. I would now like to turn the conference over to Ms. Courtney Solberg, Associate Director of Investor Relations. Please go ahead, ma'am.Courtney SolbergSenior Manager of Investor Relations Good afternoon, and thank you for joining our call to discuss our Phase I data of cemsidomide in multiple myeloma. These data were presented at the IMS Annual Meeting earlier today. We will be making forward-looking statements today, and Slide 2 contains our legal discl ...